What is Doxil?
Doxil® is a chemotherapy drug used in cancer treatment. It is a reformulated version of doxorubicin (Adriamycin®), a cancer drug that has been used for many years in traditional chemotherapy regimens in multiple myeloma.
Doxil is approved for use in combination with Velcade® (bortezomib, Takeda Oncology) to treat patients with myeloma who have not previously received Velcade and have received at least one prior therapy.
Doxil is also known as doxorubicin HCl liposome injection or pegylated liposomal doxorubicin (PLD). It is distributed by Janssen Products, LP in the United States. Doxil is also approved for the treatment of patients with ovarian cancer and in patients with AIDS-related Kaposi’s sarcoma.